Results 31 to 40 of about 36,879 (249)

Eosinophilia complicated with venous thromboembolism: A case report

open access: yesWorld Journal of Clinical Cases, 2022
Eosinophilia is an increase of more than 0.5 × 109/L in the number of eosinophils; it is a systemic condition with an unknown etiology and is often accompanied by multiple impaired organ functions. The clinical manifestations of the disease are highly variable and diverse, rendering identification of the diagnosis challenging; hence, diagnosis and ...
Su, Wei-Qiang   +6 more
openaire   +2 more sources

The incidence of haemorrhagic and thromboembolic events after breast cancer surgery in patients treated with pharmacological thromboprophylaxis [PDF]

open access: yesJournal of Clinical and Investigative Surgery, 2019
Background. Hemorrhagic events and venous thromboembolic disease, including pulmonary embolism and deep venous thrombosis, are the most important complications after breast cancer surgery.
Cosmin A. Andrei   +5 more
doaj   +1 more source

Sex‐, Race‐ and Ethnicity‐Based Differences in Thromboembolic Events Among Adults Hospitalized With COVID‐19

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Patients hospitalized with COVID‐19 have an increased risk of thromboembolic events. Whether sex, race or ethnicity impacts these events is unknown.
Sadia Ilyas   +9 more
doaj   +1 more source

Epidemiology and pathophysiology of cancer-associated thrombosis [PDF]

open access: yes, 2010
Venous thromboembolism (VTE) is a common complication in patients with malignant disease. First recognised by Bouillard in 1823 and later described by Trousseau in 1844, multiple studies have since provided considerable evidence for a clinical ...
Pasi, J   +5 more
core   +1 more source

Cancer and thrombosis: Managing the risks and approaches to thromboprophylaxis [PDF]

open access: yes, 2006
Patients with cancer are at increased risk of venous thromboembolism (VTE) compared with patients without cancer. This results from both the prothrombotic effects of the cancer itself and iatrogenic factors, such as chemotherapy, radiotherapy, indwelling
Erhard Hiller, Hiller, Erhard
core   +1 more source

The thrombodynamics test as a new opportunity for a polyclinic surgeon to monitor postoperative venous thromboembolic complications

open access: yesАмбулаторная хирургия, 2023
Introduction. Postoperative venous thromboembolic complications – a frequent and difficult to control problem for a polyclinic surgeon. Aim. To study and evaluate the possibilities of using the thrombodynamics test for the control of postoperative venous
A. A. Babitskiy   +5 more
doaj   +1 more source

Preconception venous thromboembolism and placenta‐mediated pregnancy complications [PDF]

open access: yesJournal of Thrombosis and Haemostasis, 2015
Placenta-mediated complications are leading causes of maternal and fetal morbidity and mortality. We hypothesized that a preconception history of venous thromboembolism (VTE) is associated with increased risk of placenta-mediated pregnancy complications.A nationwide population-based cohort study of all singleton pregnancies leading to delivery from ...
Hansen, A T   +6 more
openaire   +2 more sources

CLINICAL DISCUSSION OF A PATIENT WITH RECURRENT VENOUS THROMBOEMBOLIC COMPLICATIONS [PDF]

open access: yes, 2017
The article presents a clinical discussion of the patient with recurrent venous thromboembolic complications. It also provides recommendations on modern principles of diagnostics, choice of medical tactics in patients with this pathology.
A. L. KOMAROV
core   +2 more sources

Arterial and Venous Thromboembolic Complications in 832 Patients with BCR-ABL-Negative Myeloproliferative Neoplasms [PDF]

open access: yes, 2023
Wille K, Deventer E, Sadjadian P, et al. Arterial and Venous Thromboembolic Complications in 832 Patients with BCR-ABL-Negative Myeloproliferative Neoplasms. Hämostaseologie .
Wille, Kai   +9 more
core   +1 more source

CONSIDERING QUESTION OF SAFETY OF DIRECT ORAL ANTICOAGULANTS: THE RESULTS OF THE COMPARISON OF APIXABAN AND WARFARIN

open access: yesАтеротромбоз, 2018
The review analyzes data on the safety of apixaban for the prevention of thromboembolic complications in patients with nonvalvular atrial fibrillation and venous thromboembolic complications obtained in randomized controlled studies.
Igor S. Yavelov
doaj   +1 more source

Home - About - Disclaimer - Privacy